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Abstract 
The number of breast cancer patients is increasing high in the 
world. This study aims to determine the chemopreventive effect of 
a combination of ethanolic extracts of tea leaves and mandarin 
peel in silico and in vitro on T47D breast cancer cells. Extraction by 
the maceration method used ethanol solvent 70%. The research is 
an in silico molecular docking utilized software of Autodock Vina to 
determine the binding affinity of tangeretin compounds and 
Epigallocatechin gallate (EGCG) on HER-2 protein. The antioxidant 
test used the 2,2-diphenyl-1-picrylhydrazyl (DPPH) method to 
determine the antioxidant activity of the combination of tea leaf 
and mandarine peel (CTM) extract. The in vitro test used the 
method of 3-(4,5-dimethyltiazol-2-il) -2,5-diphenyltetrazolium 
bromide (MTT) to determine the value of IC50 from CTM on T47D 
breast cancer cells. The result of this study showed that CTM had a 
vigorous antioxidant activity with an IC50 value of 83 μg/ml. CTM 
had a weak cytotoxic activity with an IC50 value of 1889 μg/ml. 
Molecular tethering results of tangeretin and EGCG compounds 
produced a docking score of -6.6 and -5.0 kcal/mol with docking 
score proportion consisting of -4.9 kcal/mol of original ligand, -6.1 
kcal/mol of doxorubicin and -4.5 kcal/mol of 5-fluorouracil. CTM 
had potential as a chemopreventive agent based on the robust 
antioxidant activity data on T47D breast cancer cells and molecular 
docking on the HER-2 protein. 
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Breast cancer is a deadly cancer attacking 
women with a high prevalence rate. In 
2012, there were 26 cases per 100,000 
women.1 One of the proteins that mainly 
causes breast cancer cell growth is HER-2. 
In the majority of breast cancer patients, 
HER-2 protein experiences uncontrolled 
expression through gene amplification 
that increases HER-2 protein expression 
up to 40-100 times.2-5 Breast cancer can 
grow and spread into its surrounding 
tissue, such as lymph nodes, and then 
enter the blood vessels and even to other 
organs (lungs, bones, liver, and brain).6 
Common treatments for breast cancer 
patients are such as chemotherapy, 
surgery, and radiation.7 However, these 
treatments are expensive and also often 
cause adverse side effects, which can kill 
the healthy surrounding tissue and even 
the effects of immunosuppression. it is 
necessary to innovate in defeating cancer, 
for example, using safer alternative 
treatments, such as plant extracts.8 
 
Natural ingredients that have the 
potential as a chemopreventive agent are 
tea leaves and mandarin (mandarin 
orange) peels. Tea leaves contain a 
flavonoid-polyphenol compound, 
epigallocatechin gallate (EGCG), which is 
proven to have a substantial antioxidant 
property. Mandarin (Citrus reticulata) peel 
contains a compound called ‘tangeretin’ 
that can potentially inhibit tumor cell 
growth, which is proven to be able to 
induce cell-cycle G1 arrest processes.9 
Considering all those benefits, this study 
aims to determine the chemopreventive 
effect of a combination of ethanolic 
extracts of tea leaves and mandarine 
peels in silico and in vitro. The 
combination of both extracts is expected 
to have a good synergy effect that can 
inhibit the development of cancer cells 





Tea leaves (Camellia sinensis) were 
obtained from the Kaliurang area, 
Yogyakarta, and mandarin peel (Citrus 
reticulata) were obtained from the Bantul 
region, Yogyakarta. The determination of 
both plants was carried out in the 
Laboratory of Pharmacy Biology, Faculty 
of Pharmacy, UGM Yogyakarta. 
 
Macerating Extraction 
The selection of the extraction method 
was based on the natures and 
compositions to be isolated.10 Extraction 
was conducted using ethanol solvent 70% 
and stirred routinely every day for five 
days. After that, the pulp was re-
macerated for two days. After two days, 
the maceration was filtered again and was 
then evaporated using a Rotary 
Evaporator until a thick extract was 
obtained.11 
 
Antioxidant Test of DPPH 
The DPPH method was based on the free-
radical reduction of DPPH with maximum 
absorption at a wavelength of 517 nm, 
which produced a purple color in 
ethanol.12 After that, 2 mL of vitamin C 
solution was taken, which was the sample 
solution at various concentration series 
made into a 10-mL volumetric flask. The 
solution was added with 2 mL of DPPH 
and a methanol solution into the limit 
mark. The solution was vortexed for 30 
seconds and left alone within the 
operating time. Uptake was read at  
maximum and replicated three times. 
 
Cytotoxic Test of MTT Assay 
This method was based on the 
breakdown of tetrazolium salt or yellow 




MTT (3- (4,5-dimethylthyazol-2-yl) -2,5-
diphenyl tetrazolium bromide) by 
dehydrogenase succinate enzyme 
contained in the cell mitochondria to turn 
into purplish blue formazan crystals.13 
Cells with a density of 70-80% (confluent) 
were distributed into 96 well plates, 
observed under an inverted microscope to 
identify the cells’ distribution, and then 
incubated for 48 hours so that the cells 
could adapt and attach to the bottom of 
the wells. On the following day, the 
media in the wells were dumped by 
turning the well plates over the dump, 
then drained with a tissue. The wells were 
washed using 100 µL PBS which was 
added to all wells filled with cells, and 
then they were discarded. Furthermore, a 
series of concentrations of the test 
sample and culture media containing 
0.2% DMSO (control) was added and then 
re-incubated for 24 hours. At the end of 
the incubation, culture media containing 
the sample were removed and washed 
with 100 µL PBS, then added with the 
MTT reagent. In this case, living cells 
would react with MTT to form purple 
formazan crystals. After 4 hours of 
incubation, the condition of the cells was 
examined under an inverted microscope. 
When formazan was created, a 200 μL 
SDS stopper solution was added into 
0.1% HCl to dissolve the formazan 
crystals. The well plates were then 
covered with aluminum foil and incubated 
in a dark place at room temperature for 3 
hours. Upon that process, the aluminum 
foil was opened and shaken for 10 
minutes. The absorption was read with an 
ELISA reader at a wavelength of 595 nm. 
Based on the absorbance data, the 
percentage of living cells and IC50 values 
could be calculated. 
 
Molecular Docking Test 
Molecular docking is a computational 
method used to predict the interaction 
between ligands and receptors or proteins 
to obtain the value which describes their 
total bond energy. The protein structure 
selected as the target of molecular 
docking in this study was HER-2 (PDB ID: 
3PP0). The structure was downloaded 
from the Protein Data Bank (PDB) 
through www.rcsb.org; thus, the protein’s 
PDB ID could be identified. The 
application used for protein and ligand 
preparation in this study was DS 
Visualizer. RMSD value was determined 
by filling in the Windows Command 
Prompt according to the code; therefore, 
some conformations would appear. Each 
conformation showed its RMSD affinity 
value, then the conformation, which had 
an RMSD value of less than 2 Å, was 
selected. The visualization process of 
docking results used the DS Visualizer 
app. The visualization was to determine 
the position and the image of the bond 
between proteins and ligands in 3D. 
 
RESULTS AND DISCUSSION 
 
Plant Determination 
The results of the determination showed 
that the simplisia used in this study was 
tea leaf (Camellia sinensis) and mandarin 
orange peel (Citrus reticulata). 
 
Macerating Extraction 
The maceration method in this study used 
ethanol solvent 70%, 10 L for 1 kg of dried 
tea leaf powder, and 1 kg of dried 
mandarin peel powder. Based on the 
filtering result, 2,450 ml of liquid extract 
was obtained. It was then dried using a 
rotary evaporator and produced 27.3 
grams of thick tea leaf extract (TLE) with 
a dark green color and 26.4 grams of a 
concentrated mandarin peel extract 
(MPE) with a dark yellowish-green color. 
Both tea leaf extract and mandarin peel 
extract were mixed to get a combined 
extract. 
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Antioxidant Test of DPPH 
Absorbance data of DPPH antioxidant 
test results can be seen in Tables 1 and 2, 
and the graphic is shown in Figures 1 and 
2. Also, the IC50 value of the antioxidant 
test is shown in Table 3. 
 
Table 1. Data of comparative inhibition 








0.5  0.641  0.702  8.73  
1.0  0.638  0.702  9.11  
2.0  0.625  0.702  11.01  
5.0  0.557  0.702  20.76  
10.0  0.402  0.702  42.76  
20.0  0.189  0.702  73.04  
30.0  0.055  0.702  92.22  
 









5.0 0.721 0.702 -2.61 
7.5 0.703 0.702 -0.09 
10.0 0.664 0.702 5.46 
15.0 0.633 0.702 9.87 
20.0 0.472 0.702 32.87 
30.0 0.381 0.702 45.80 
40.0 0.346 0.702 50.78 
 
Table 3. IC50 value of antioxidant test for 







Vitamin C y=2.9913x+7.5319 14.19 Very strong 
 R2= 0.9859   
CTM y=0.6427x-3.3458 83.00 Strong 
 R2=0.9698   
 
Table 4. The result of the molecular 








Native ligand 1.957 -4.9 7 
EGCG 1.343 -6.6 2 
Tangeretin 1.197 -5.0 4 
Doxorubicin 1.542 -6.1 4 
5-Fluorouracil 1.576 -4.5 3 
Molecular Docking with Autodock Vina 
Molecular docking was conducted using 
the Autodock Vina application. Open 
babel, and the shape of the structure 
were then visualized in 2D and 3D with 
the DS Visualizer. The data on the 
molecular docking results can be seen in 
Table 4. 
 
Cytotoxic Test of MTT Assay 
The cytotoxic test was performed to 
determine MTT Assay activity towards 
T47D breast cancer cells by giving CTM 
extract treatment shown in Table 5. 
 
Table 5. Data of living cell after CTM 










100 0.130 0.014 4.308 
400 0.128 0.003 3.798 
800 0.124 0.002 3.122 
1000 0.118 0.001 2.009 
Average 
Absorbance 
Cell Control 0.663  
Media 0.103  
Equation 
 
y = -0.0024x + 4.6713 
 R2 = 0.9233 
 IC50=1889 μg/ml 
 
Cytotoxic Test of MTT Assay 
The cytotoxic test was performed to 
determine MTT Assay activity towards 
T47D breast cancer cells by giving CTM 
extract treatment, as shown in Table 6. 
 
Table 6. Data of living cell after CTM 










100 0.130 0.014 4.308 
400 0.128 0.003 3.798 
800 0.124 0.002 3.122 
1000 0.118 0.001 2.009 
Average 
Absorbance 
Cell Control 0.663  
Media 0.103  
Equation 
 
y = -0.0024x + 4.6713 
 R2 = 0.9233 
 IC50=1889 μg/ml 
 






Figure 1. Chart of Vitamin C Inhibition 
 
Figure 2. Chart of CTM Extract Inhibition 
 
 
Figure 3. 3D structure of geometry optimization results: (A) Native ligand (B) EGCG 
(C)Tangeretin (D) Doxorubicin (E) 5-Fluorouracil 
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Figure 4. 2D structure of interaction of Test Compounds on HER-2 in atomic pockets: (A) 
Native Ligand (B) EGCG (C) Tangeretin (D) Doxorubicin (E) 5-Fluorouracil 
 
Figure 5. Graphic of Living Cells T47D with CTM Extract Treatment (%) 
 
 
Figure 6. Changes in T47D cell morphology (A) Before the extract treatment (B) Shortly 
after the extract treatment (C) After the extract treatment (sign ‘’ indicates damaged or 
dead cells) 
 




























(C) (A) (B) 




Antioxidant test results showed an IC50 
value of vitamin C compounds was 14.87 
μg/ml. Whereas, the IC50 value of TLE and 
MPE combination was 83.00 μg/ml, which 
was weaker in capturing radicals 
compared to vitamin C. It occurred as the 
combination sample (CTM) was still in the 
form of crude extracts; thus, the number 
of active compounds that could inhibit 
free radical activity was likely to be 
smaller. However, IC50 < 100 μg/ml was 
obtained and classified as antioxidants 
with vigorous activity. Therefore, the 
combination of CTM extract had strong 
potential in the activity of capturing free 
radical compounds. 
 
Referring to a similar study, an 
antioxidant test of Kemuning extract 
(Murraya paniculata (L) Jack) produced an 
IC50 value of 126.17 μg/ml, and 
antioxidant analysis of mangosteen peel 
extract (Garcinia mangostana L.) resulted 
in an IC50 value of 44.49 μg/ml.15 
Compared to this, CTM extract had more 
substantial antioxidant potential than 
Kemuning extract. However, it was 
weaker compared to mangosteen peel 
extract.16 
 
The results of molecular docking showed 
that the EGCG compound had the most 
vigorous inhibitory activity on the HER-2 
protein with a docking score of -6.6 
kcal/mol, compared to other comparative 
compounds. Visualization of the docking 
results showed that EGCG compounds 
were comparable to doxorubicin which 
had 7 bounds interacting with amino acid 
glutamine at position 407 (GLN 407), 
glutamic acid at position 299 (GLU 299), 
glutamic acid at position 383 (GLU 383), 
threonine at position 301 (THR 301), 
glutamic acid at position 382 (GLU 382), 
lysine at position 347 (LYS 347), and 
phenylalanine at position 349 (PHE 349). 
It was higher than the original ligand, 
which only had five bonds.  
 
The tangeretin compound interacted by 
binding to 6 bonds interacting with the 
amino acid threonine at position 301 (THR 
301), lysine at position 346 (LYS 346), 
lysine at position 347 (LYS 347), glutamine 
at position 383 (GLU 383), and valine at 
position 300 (VAL 300).17-20 The 5-FU 
ligand and tangeretin interacted with five 
bonds of amino acids, as many as the 
original ligand. The more the bonds are 
formed between the ligand and the target 
protein, the stronger the potential activity 
of a compound will be. It indicates that 
the EGCG compound in silico has a strong 
potential to inhibit HER-2 protein.21 
 
Based on the cytotoxic test results, CTM 
extract had a weak potential in inhibiting 
the viability of T47D breast cancer cells 
with IC50 values of 1889 μg/ml. It was 
probably due to the small amount of 
tangeretin compound content in CTM 
extracts, so the cytotoxic effect was not 
reliable. The tangeretin flavonoid 
compound, which was suspected of 
having an effect as a chemopreventive 
agent, had a mechanism to induce cell 
cycle G1 arrest when the cell was in the 
restriction point phase.22-24 A restriction 
point is a point where 
hyperphosphorylation occurs that causes 
the p27 inhibitor, a p53 expression gene 
(an apoptosis gene), to be degraded. At 
this point, the reparation of damaged 
DNA occurs. If DNA damage is severe and 
cannot be repaired, it will be immediately 
eliminated to the G0 phase. The 
mechanism of the cell cycle starts with 
the entry of it from the G0 phase to the 
G1 phase due to the growth factor stimuli. 
It then causes retinoblastoma protein 
(pRb) hyperphosphorylation and DNA to 
become loose. Furthermore, it later 
enters the restriction point and the S 
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phase to replicate DNA. If there is 
damage during the synthesis, it can be 
repaired before it finally enters the M 





It can be concluded that the combination 
of ethanolic extract of tea leaves and 
mandarin orange peel (CTM) had strong 
potential as an antioxidant agent in 
chemopreventive activity based on DPPH 
and molecular docking tests. However, 
the results of the cytotoxic test showed a 
weak potential to inhibit the development 
of T47D breast cancer cells. Some 
compounds that were considered to play 
an essential role in the chemopreventive 
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